Ledger.Open graph →
SEC Form D · Amendment · filed February 26, 2020

Neurana Pharmaceuticals, Inc

Offering
$64.9M
Sold
$41.9M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN DIEGO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

Joshua F. Richardson · San Diego, CADirectorDavid F. Kabakoff · San Diego, CADirectorBrian F. Dorsey · San Diego, CADirectorDavid F. Hale · Del Mar, CADirectorKathleen D. Scott · San Diego, CAExecAlex F. Zisson · San Diego, CADirectorCraig F. Thompson · San Diego, CAExec · DirectorRandall D. Kaye, M.D · San Diego, CAExecJoshua F. Richardson · San Diego, CADirectorDavid F. Kabakoff · San Diego, CADirectorCraig F. Thompson · San Diego, CAExec · DirectorBrian F. Dorsey · San Diego, CADirectorDavid F. Hale · Carlsbad, CADirectorRandall D. Kaye, M.D · San Diego, CAExecKathleen D. Scott · San Diego, CAExecAlex F. Zisson · San Diego, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗